Is dynapenia associated with the onset and persistence of depressive and anxiety symptoms among older adults? Findings from the Irish longitudinal study on ageing

Imagem de Miniatura
Arquivos
art_CARVALHO_Is_dynapenia_associated_with_the_onset_and_persistence_2021.PDF (1.28 MB)
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
Autores
CARVALHO, Andre F.
MAES, Michael
SOLMI, Marco
LANGE, Shannon
HUSAIN, M. Ishrat
KURDYAK, Paul
REHM, Jurgen
KOYANAGI, Ai
Citação
AGING & MENTAL HEALTH, v.25, n.3, p.468-475, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: The aim of the current study was to assess the associations between dynapenia and the onset and persistence of depression and anxiety among older adults. Methods: This prospective cohort study enrolled community-living older adults (N = 5271; 51.1% females) aged >= 50 years (mean age = 63.2, standard deviation = 9.0) from The Irish Longitudinal Study on Aging (TILDA), Ireland. At baseline, participants completed a handgrip assessment. Depression was defined by a score >= 16 in the Center of Epidemiology Studies Depression (CES-D) tool and anxiety was considered when participants scored >= 8 on the anxiety section of the Hospital Anxiety and Depression Scale (HADS). Outcomes were incident and persistent depression and anxiety at two years follow-up. Multivariable logistic regression models were built for each outcome. Results: After controlling for age, sex, education, marital status, employment status, smoking, body mass index, number of chronic conditions, physical activity, and cognitive function, low handgrip strength indicative of dyapenia (< 30 Kg for men and < 20 Kg for women) was associated with a greater likelihood for incident depressive (OR = 1.44; 95%CI: 1.08-1.92) as well as for persistent depressive (OR = 1.61; 95% CI: 1.01-2.58) and anxiety (OR = 1.61; 95% CI: 1.20-2.14) symptoms. Conclusions: Dynapenia was associated with a higher odds of developing depressive symptoms as well as a greater likelihood to persistent depressive and anxiety symptoms among older adults. Our data suggest that interventions targeting muscle strength may prevent the onset of late-life depression and also may hold promise as novel therapeutic opportunities for depression and anxiety in later life.
Palavras-chave
Elderly, depression, anxiety, sarcopenia, handgrip strength, prospective, psychiatry
URI
https://observatorio.fm.usp.br/handle/OPI/39767
Referências
  1. Borim FSA, 2019, J AM MED DIR ASSOC, V20, P47, DOI 10.1016/j.jamda.2018.06.006
  2. Ashdown-Franks G, 2019, J AFFECT DISORDERS, V243, P448, DOI 10.1016/j.jad.2018.09.036
  3. Bano G, 2017, MATURITAS, V96, P10, DOI 10.1016/j.maturitas.2016.11.006
  4. Barrett A., 2011, 50 PLUS IRELAND 2011
  5. Beaudart C, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0349-4
  6. Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510
  7. Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
  8. Brooks JM, 2018, J NUTR HEALTH AGING, V22, P938, DOI 10.1007/s12603-018-1041-5
  9. Choi KW, 2019, JAMA PSYCHIAT, V76, P399, DOI 10.1001/jamapsychiatry.2018.4175
  10. Clark BC, 2012, NUTRITION, V28, P495, DOI 10.1016/j.nut.2011.12.002
  11. Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
  12. Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
  13. De Spiegeleer A, 2018, DRUG AGING, V35, P719, DOI 10.1007/s40266-018-0566-y
  14. FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
  15. Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
  16. Fukumori N, 2015, AGE AGEING, V44, P592, DOI 10.1093/ageing/afv013
  17. Gariepy G, 2016, BRIT J PSYCHIAT, V209, P286, DOI 10.1192/bjp.bp.115.169094
  18. Gordon BR, 2019, J AFFECT DISORDERS, V255, P136, DOI 10.1016/j.jad.2019.05.043
  19. Gordon BR, 2018, JAMA PSYCHIAT, V75, P566, DOI 10.1001/jamapsychiatry.2018.0572
  20. Gordon BR, 2017, SPORTS MED, V47, P2521, DOI 10.1007/s40279-017-0769-0
  21. Hertzog C., 1990, PSYCHOL ASSESSMENT, V2, P64, DOI 10.1037/1040-3590.2.1.64
  22. Kearney PM, 2011, AGE AGEING, V40, P85, DOI 10.1093/ageing/afq124
  23. Kenny R.A., 2010, DESIGN IRISH LONGITU
  24. Kim JH, 2019, J AFFECT DISORDERS, V245, P371, DOI 10.1016/j.jad.2018.11.017
  25. Kim KH, 2019, KOREAN J FAM MED, V40, P9, DOI 10.4082/kjfm.17.0074
  26. Kohler CA, 2017, ACTA PSYCHIAT SCAND, V135, P373, DOI 10.1111/acps.12698
  27. Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0
  28. Lee L, 2017, CAN FAM PHYSICIAN, V63, pE51
  29. Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277
  30. Maurya PK, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.08.016
  31. McDowell CP, 2018, EXP GERONTOL, V104, P147, DOI 10.1016/j.exger.2018.02.010
  32. Mendes J, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0590-5
  33. Musalek C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121447
  34. Nolan A., 2014, 50S CHANGING IRELAND
  35. Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46
  36. Osimo EF, 2019, PSYCHOL MED, V49, P1958, DOI 10.1017/S0033291719001454
  37. Padilha CS, 2015, AGE, V37, DOI 10.1007/s11357-015-9841-6
  38. RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
  39. Ribeiro AS, 2017, INT J SPORT NUTR EXE, V27, P439, DOI 10.1123/ijsnem.2016-0322
  40. Rijk JM, 2016, GERIATR GERONTOL INT, V16, P5, DOI 10.1111/ggi.12508
  41. Sardeli AV, 2018, EXP GERONTOL, V111, P188, DOI 10.1016/j.exger.2018.07.021
  42. Schuch FB, 2019, DEPRESS ANXIETY, V36, P846, DOI 10.1002/da.22915
  43. Schuch FB, 2018, AM J PSYCHIAT, V175, P631, DOI 10.1176/appi.ajp.2018.17111194
  44. Smith KJ, 2018, EXP GERONTOL, V102, P109, DOI 10.1016/j.exger.2017.12.005
  45. Smith L, 2019, SCAND J MED SCI SPOR, V29, P1604, DOI 10.1111/sms.13497
  46. Sousa-Santos AR, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0625-y
  47. Soysal P, 2017, AGEING RES REV, V36, P78, DOI 10.1016/j.arr.2017.03.005
  48. Soysal P, 2016, AGEING RES REV, V31, P1, DOI 10.1016/j.arr.2016.08.006
  49. Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382
  50. Valkanova V, 2013, J AFFECT DISORDERS, V150, P736, DOI 10.1016/j.jad.2013.06.004
  51. Veronese N, 2017, PHYS THER, V97, P659, DOI 10.1093/ptj/pzx017
  52. Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251
  53. Whelan BJ, 2013, J AM GERIATR SOC, V61, pS265, DOI 10.1111/jgs.12199
  54. ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - LIM/27
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/05